CervoMed Inc.

The momentum for this stock is not very good. CervoMed Inc. is not a good value stock. CervoMed Inc. is not a good growth stock. CervoMed Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in CervoMed Inc..

News

CervoMed (NASDAQ:CRVO) Trading 1.2% Higher

Zolmax Shares of CervoMed Inc. (NASDAQ:CRVO - Get Free Report) rose 1.2% on Wednesday . The company traded as high as $16.50 and last traded at $15.71. Approximately 67,855 shares changed hands during...\n more…

CervoMed to Participate in Upcoming Investor Conferences

Globe Newswire BOSTON, Aug. 27, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that the...\n more…

We're Not Very Worried About CervoMed's (NASDAQ:CRVO) Cash Burn Rate

Simply Wall St There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, CervoMed...\n more…

CervoMed Featured in Fortune for Advances in the Treatment of Dementia with Lewy Bodies

Globe Newswire BOSTON, Aug. 22, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced its recent...\n more…

FY2024 Earnings Forecast for CervoMed Inc. (NASDAQ:CRVO) Issued By Brookline Capital Management

Ticker Report CervoMed Inc. (NASDAQ:CRVO - Free Report) - Research analysts at Brookline Capital Management boosted their FY2024 earnings estimates for CervoMed in a research report issued on Monday, August 12th...\n more…

CervoMed: A Strong Buy on Pioneering DLB Treatment and Solid Financial Footing

TipRanks Financial Blog CervoMed (CRVO - Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit Roy from JonesTradin...\n more…